《美股业绩》Salesforce季度收入胜预期 市後升逾4%
道指成分股,美国商用软件巨擘Salesforce(CRM.US)公布截至4月底止首财季业绩。季度纯利4.69亿美元,对上年度同期为9,900万美。每股季度摊薄纯利50美仙,经调整後为1.21美元。季度收入59.63亿美元,按年升22.6%,高於市场预期的58.9亿美元。
公司去年12月同意收购Slack,为商业机构员工、客户及业务夥伴沟通联系建立统一平台,与微软的Team软件进行竞争。公司预期现财季收入介乎62.2亿至62.3亿美元,每股经调整季度纯利介乎91至92美仙。
公司股价在延长交易时段升4.2%,报235.4美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.